627 - The Future of Biopharma: AI, Automation, and Clinical Trial Breakthroughs at BIO2026 episode artwork

EPISODE · Jul 27, 2026 · 34 MIN

627 - The Future of Biopharma: AI, Automation, and Clinical Trial Breakthroughs at BIO2026

from Talking HealthTech

In this episode of Talking HealthTech, Peter Birch speaks with Jayden Rogers (CEO, Linear Clinical Research), Dr Stacie Calad-Thomson (Business Development Lead, Nvidia for Pharma Labs and Manufacturing), Arjun Bhat (Co-Founder, Clinrol), and Tran Le (General Manager, Hippocratic AI).The conversations cover the changing landscape of clinical trials and drug discovery, the growing role of AI in patient recruitment and drug development, and innovations in technology and operational efficiency in life sciences.The discussion covers why Australia has become an attractive destination for global clinical trials, from its regulatory environment and world-class clinicians through to the integrated networks that help international sponsors find the right partners.It also looks at the practical realities of running a trial site, where regulatory approvals, staffing, patient engagement, and sensitive data all need to be managed at once, and how purpose-built platforms are taking on the repetitive work so research teams can focus on patient care.This episode was recorded during the BIO International Convention in San Diego, featuring conversations with scientists, founders, investors, and healthcare decision-makers addressing challenges and opportunities across the biotech sector.Key Takeaways🧬 AI and automation are transforming clinical trial recruitment, streamlining patient matching, eligibility screening, and follow-up tasks🚀 Australia’s reputation for clinical trials continues to grow, supported by a strong regulatory environment and quality healthcare ecosystem💡 Open source tools and AI models are making computational drug discovery more accessible for non-specialists in science and medicine🧑‍⚕️ Technology advancements allow clinicians and trial sites to focus more on patient care by reducing manual and repetitive efforts🔗 Collaboration across pharma, biotechs, technology providers, and regulators is essential to tackle operational bottlenecks and accelerate drug developmentTimestamps00:00 - Introduction01:07 - Jayden Rogers, CEO, Linear Clinical Research08:25 - Dr Stacie Calad-Thomson, Business Development, NVIDIA17:55 - Arjun Bhat, Co-Founder, Clinrol26:52 - Tran Le, General Manager of Life Sciences, Hippocratic AICheck out the episode and full show notes on the Talking HealthTech website.If you’re enjoying the show and want access to exclusive healthtech discussions, meetups, and member-only content, you can learn more about becoming a THT+ Solo Member here: talkinghealth.tech/solo_shownotesAnd if this episode was useful, leaving a review or sharing it with someone in the industry always helps.Mentioned in this episode:Sign Up to the Free Talking Healthtech NewsletterSign up to the free Talking HealthTech newsletter for weekly digital health news, events, jobs, partner updates and Pete’s take on what matters across the sector: talkinghealthtech.com/newsletter

Episode metadata supplied by the publisher feed · Published Jul 27, 2026

Embed this episode

NOW PLAYING

627 - The Future of Biopharma: AI, Automation, and Clinical Trial Breakthroughs at BIO2026

0:00 34:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking HealthTech?

This episode is 34 minutes long.

When was this Talking HealthTech episode published?

This episode was published on July 27, 2026.

Can I download this Talking HealthTech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!